- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Histone Deacetylase Inhibitors
Total 64228 results
-
Novartis PharmaceuticalsNo longer availableMultiple MyelomaUnited States
-
BayerCompleted
-
University of RochesterMassey Cancer CenterCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4S Neuroblastoma | Stage 4 NeuroblastomaUnited States, Canada
-
Translational Research in OncologyTerminated
-
Therapeutic Advances in Childhood Leukemia ConsortiumNovartisCompletedNon-Hodgkin's Lymphoma | Lymphoblastic Leukemia, Acute, Childhood | Hodgkin's Disease | Myelogenous Leukemia, Acute, ChildhoodUnited States
-
M.D. Anderson Cancer CenterCompleted
-
National Cancer Institute (NCI)CompletedMale Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast CancerUnited States
-
National Cancer Institute (NCI)CompletedThymic Carcinoma | ThymomaUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Spectrum Pharmaceuticals, IncOnxeoCompletedSolid Tumor | Hematological MalignancyUnited States
-
Merck Sharp & Dohme LLCCompletedMyelodysplastic Syndromes | Leukemia, Myelocytic, Acute Myelodysplastic Syndromes
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)TerminatedStage IIIA Non-Small Cell Lung Cancer | Stage IIIB Non-Small Cell Lung Cancer | Stage IV Non-Small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCCompletedAdvanced Cancer Relapsed | Advanced Cancer Refractory
-
OnxeoCompletedAcute Myeloid LeukemiaUnited Kingdom, Germany, France
-
OnxeoCompletedOvarian Cancer | Fallopian Tube Cancer | Bladder Cancer | Epithelial Ovarian CancerUnited States, Denmark, United Kingdom
-
OnxeoSpectrum Pharmaceuticals, IncCompletedDose Escalation: Solid Tumors | MTD: Soft Tissue SarcomasDenmark, United Kingdom
-
OnxeoTerminatedNon-Hodgkin's Lymphoma | Cutaneous T-Cell Lymphoma | Peripheral T-Cell LymphomaUnited States, Germany, Israel, France, Thailand
-
OnxeoSpectrum Pharmaceuticals, IncCompletedCarcinoma of Unknown PrimaryUnited States, Germany, France, Denmark
-
University Health Network, TorontoNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificCanada
-
University of PittsburghNovartis PharmaceuticalsTerminatedNon-Small Cell Lung CancerUnited States
-
Ohio State University Comprehensive Cancer CenterMerck Sharp & Dohme LLCCompletedLymphoma | Small Intestine CancerUnited States
-
OnxeoCompleted
-
OnxeoCompletedMultiple MyelomaUnited States, Denmark, United Kingdom, Norway
-
OnxeoSpectrum Pharmaceuticals, IncCompletedLymphoma | Solid TumorUnited States, Denmark, United Kingdom
-
OnxeoTerminatedMultiple MyelomaUnited States
-
Merck Sharp & Dohme LLCTerminatedMyelodysplastic Syndromes | Blood Disease | Bone Marrow Disease
-
Mirati Therapeutics Inc.TerminatedHodgkin's LymphomaUnited States, Canada
-
Merck Sharp & Dohme LLCTerminatedStage IIIB or IV Non-Small Cell Lung Cancer
-
Mirati Therapeutics Inc.CompletedLymphocytic Leukemia, ChronicUnited States, Canada
-
Mirati Therapeutics Inc.CompletedLymphomaUnited States, Canada
-
Mirati Therapeutics Inc.CompletedMyelodysplastic Syndrome | Acute Myelogenous LeukemiaUnited States
-
Mirati Therapeutics Inc.TerminatedHodgkin Lymphoma | Non-Hodgkin Lymphoma (Follicular or Large Diffuse B-cell Lymphoma or Mantle Cell Lymphoma)United States
-
Mirati Therapeutics Inc.CompletedTumorsUnited States, Canada
-
Mirati Therapeutics Inc.TerminatedMyelodysplastic Syndromes | Myelogenous Leukemia, AcuteUnited States, Canada
-
Prof Jamie CavenaghNovartis; Myeloma UKUnknownMultiple MyelomaUnited Kingdom
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); National Comprehensive Cancer NetworkCompletedPancreatic Cancer | Periampullary AdenocarcinomaUnited States
-
SCRI Development Innovations, LLCNovartisCompletedBreast CancerUnited States
-
University of Southern CaliforniaNovartisTerminatedStage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal CancerUnited States
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Mirati Therapeutics Inc.TerminatedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States, Canada, United Kingdom
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCTerminated
-
Merck Sharp & Dohme LLCTerminated
-
National Cancer Institute (NCI)TerminatedMale Breast Cancer | Stage IV Breast Cancer | Recurrent Breast CancerUnited States
-
M.D. Anderson Cancer CenterMerck Sharp & Dohme LLCCompletedAcute Myeloid Leukemia (AML) | Myelodysplastic Syndrome (MDS)United States
-
Ronald HoffmanNovartisUnknownPrimary Myelofibrosis | Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase | Post-Essential Thrombocythemia Related MyelofibrosisUnited States
-
Merck Sharp & Dohme LLCTerminated